Published in Ann Rheum Dis on June 01, 1978
Bacterial, fungal, parasitic, and viral myositis. Clin Microbiol Rev (2008) 1.66
Immunosuppression and Chagas disease: a management challenge. PLoS Negl Trop Dis (2013) 1.12
Inhibition of muscle differentiation by trypanosoma cruzi. Proc Natl Acad Sci U S A (1983) 1.02
Parasitic infections and myositis. Parasitol Res (2011) 0.79
Trypanosoma cruzi Causes Paralyzing Systemic Necrotizing Vasculitis Driven by Pathogen-Specific Type I Immunity in Mice. Infect Immun (2016) 0.76
Nonbacterial myositis. Curr Infect Dis Rep (2010) 0.75
Chagasic cardiopathy. Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation (1974) 2.80
Chagasic cardiopathy. Antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation (1974) 2.02
Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med (1972) 1.90
Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia. Clin Exp Immunol (1975) 1.38
[Pathology of prolonged experimental Chagas' disease]. Rev Inst Med Trop Sao Paulo (1970) 0.94
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer (2000) 4.96
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1. J Virol (1992) 4.85
A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study. Lancet (1990) 2.89
Fluorescent antibody test for the serodiagnosis of American trypanosomiasis. Technical modification employing preserved culture forms of Trypanosoma cruzi in a slide test. Rev Inst Med Trop Sao Paulo (1968) 2.62
An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol (1992) 2.41
Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol (1986) 2.37
Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect Immun (1988) 2.37
Immunoglobulin G and immunoglobulin M enzyme-linked immunosorbent assays and defined toxoplasmosis serological patterns. Infect Immun (1978) 2.15
Differential staining of collagens type I, II and III by Sirius Red and polarization microscopy. Arch Histol Jpn (1978) 2.12
The importance of measuring cotinine levels to identify smokers in clinical trials. Clin Pharmacol Ther (1994) 2.11
A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer. Oncogene (2000) 2.07
Direct localization and visualization of hyaluronate lyase activity by agar gel electrophoresis. Proc Soc Exp Biol Med (1967) 2.00
There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys (1999) 1.96
Neurodevelopment and predictors of outcomes of children with birth weights of less than 1000 g: 1992-1995. Arch Pediatr Adolesc Med (2000) 1.95
Multiple Trypanosoma cruzi antigens containing tandemly repeated amino acid sequence motifs. Mol Biochem Parasitol (1988) 1.91
Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease. J Clin Microbiol (1996) 1.90
Enhanced susceptibility of penicillin-resistant staphylococci to phagocytosis after in vitro incubation with low doses of nafcillin. Proc Soc Exp Biol Med (1974) 1.76
Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol (2001) 1.74
Protective effects of tumor necrosis factor in experimental Legionella pneumophila infections of mice via activation of PMN function. J Leukoc Biol (1988) 1.73
Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes. J Immunol (1988) 1.70
Differences in HLA class II alleles of isolated South American Indian populations from Brazil and Argentina. Hum Immunol (1993) 1.69
Rheumatoid factors as a cause for false positive IgM anti-toxoplasma fluorescent tests. A technique for specific results. Rev Inst Med Trop Sao Paulo (1973) 1.68
Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor. J Virol (1990) 1.65
Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J Immunol (1986) 1.62
Effects of RES "blockade" on antibody-formation. I. Suppressed cellular and humoral haemolysin responses in mice injected with carbon particles. Immunology (1969) 1.61
Radiometric detection of bacteremia: requirement for terminal subcultures. J Clin Microbiol (1977) 1.61
Cross-reactivity in fluorescence tests for Trypanosoma and Leishmania antibodies. A simple inhibition procedure to ensure specific results. Am J Trop Med Hyg (1969) 1.60
Immunoenzymatic absorption test for serodiagnosis of paracoccidioidomycosis. J Clin Microbiol (1984) 1.57
Bacterial heat shock proteins directly induce cytokine mRNA and interleukin-1 secretion in macrophage cultures. Infect Immun (1994) 1.54
Cryptococcal capsular polysaccharide-induced modulation of murine immune responses. Infect Immun (1982) 1.47
Fatigue in Parkinson's disease. Neurology (1993) 1.46
Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol (1999) 1.45
Legionella pneumophila-induced blastogenesis of murine lymphoid cells in vitro. Infect Immun (1984) 1.39
Building collaborative relationships with families of the mentally ill. Hosp Community Psychiatry (1988) 1.38
Variability of X-ray emission from M87. Nature (1971) 1.38
Vibrio vulnificus resists phagocytosis in the absence of serum opsonins. Infect Immun (1985) 1.35
Diagnostic information from serological tests in human toxoplasmosis. I. A comparative study of hemagglutination, complement fixation, IgG and IgM-immunofluorescence tests in 3,752 serum samples. Rev Inst Med Trop Sao Paulo (1976) 1.34
Temperature control of initiation of protein synthesis in Escherichia coli. J Mol Biol (1971) 1.32
Immunosuppressive effects of Friend and Rauscher leukemia disease viruses on cellular and humoral antibody formation. J Natl Cancer Inst (1968) 1.31
Molecular markers in acute and chronic phases of human toxoplasmosis: determination of immunoglobulin G avidity by Western blotting. Clin Diagn Lab Immunol (2000) 1.31
Three years of collaboration on the standardization of Chagas' disease serodiagnosis in the Americas: an appraisal. Bull Pan Am Health Organ (1986) 1.31
Enhancement of human monocyte function against Candida albicans by the colony-stimulating factors (CSF): IL-3, granulocyte-macrophage-CSF, and macrophage-CSF. J Immunol (1989) 1.30
Outcomes of extremely low birth weight infants. Pediatrics (1996) 1.28
Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophila infection. J Immunol (2000) 1.28
Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain Behav Immun (1995) 1.28
The cannabinoid system and cytokine network. Proc Soc Exp Biol Med (2000) 1.27
Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun (1994) 1.27
[Serological survey of the prevalence of Chagas' infection in Brazil, 1975/1980]. Rev Inst Med Trop Sao Paulo (1985) 1.26
Viral hepatitis, type A. Identification by specific complement fixation and immune adherence tests. N Engl J Med (1975) 1.25
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
Population study of triazolam pharmacokinetics. Br J Clin Pharmacol (1986) 1.24
Immunosuppression by leukemia viruses. I. Effect of Friend disease virus on cellular and humoral hemolysin responses of mice to a primary immunization with sheep erythrocytes. J Immunol (1968) 1.23
Differential growth of Legionella pneumophila in guinea pig versus mouse macrophage cultures. Infect Immun (1987) 1.21
Marijuana, immunity and infection. J Neuroimmunol (1998) 1.21
Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun (1994) 1.21
Differential complement activation and susceptibility to human serum bactericidal action by Vibrio species. Infect Immun (1983) 1.20
The use of filter paper blood smears in a practical fluorescent test for American Trypanosomiasis serodiagnosis. Rev Inst Med Trop Sao Paulo (1968) 1.19
Variation in antigenic determinants of p53 transformation-related protein obtained from various species. J Immunol (1983) 1.19
Advanced kidney disease in patients with hepatosplenic Manson's schistosomiasis. Rev Inst Med Trop Sao Paulo (1970) 1.19
Dorsal column stimulation for control of pain. Preliminary report on 30 patients. J Neurosurg (1972) 1.18
Diagnostic information from serological tests in human toxoplasmosis. II Evolutive study of antibodies and serological patterns in acquired toxoplasmosis, as detected by hemagglutination, complement fixation, IgG and IgM-immunofluorescence tests. Rev Inst Med Trop Sao Paulo (1976) 1.18
Cannabinoid receptors and immunity. Immunol Today (1998) 1.17
Induction of interferon-gamma and tumor necrosis factor by Legionella pneumophila: augmentation of human neutrophil bactericidal activity. J Leukoc Biol (1989) 1.17
Comparison of a radiometric procedure with conventional methods for identification of Neisseria. J Clin Microbiol (1978) 1.17
MR imaging of high-grade cerebral gliomas: value of diffusion-weighted echoplanar pulse sequences. AJR Am J Roentgenol (1994) 1.17
Electromicturition in paraplegia. Implantation of a spinal neuroprosthesis. Arch Surg (1972) 1.15
Kidney biopsy in the hepatosplenic form of infection with Schistosoma mansoni in man. Bull World Health Organ (1970) 1.15
Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts. J Immunol (1975) 1.14
Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2. J Immunol (1987) 1.14
Modulation of in vivo antibody responses by cholera toxin. J Immunol (1975) 1.14
Enzyme-linked immunosorbent assay for antibodies to Toxoplasma gondii polysaccharides in human toxoplasmosis. Infect Immun (1980) 1.13
Immunologic tolerance to Escherichia coli somatic antigen assessed by bacteriolytic and hemolytic plaque assays. J Immunol (1970) 1.13
Interferon-gamma induced resistance to Legionella pneumophila in susceptible A/J mouse macrophages. J Leukoc Biol (1991) 1.13
Role of gamma interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model. Infect Immun (1988) 1.12
The effect of RES blockade on cellular antibody formation to sheep erythrocytes. Proc Soc Exp Biol Med (1968) 1.12
Dissociation between the adjuvant vs mitogenic activity of a synthetic muramyl dipeptide for murine splenocytes. Proc Soc Exp Biol Med (1977) 1.12
Ribosomal subunits produced by cold sensitive initiation of protein synthesis. Nature (1969) 1.11
Lipoprotein(a) levels in systemic lupus erythematosus. J Rheumatol (1994) 1.11
Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study. J Pediatr Hematol Oncol (2001) 1.10
Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes (1994) 1.10
Cellular basis for the immunosuppressive properties of a leukaemogenic virus. Nature (1968) 1.09
The pharmacokinetics of doxylamine: use of automated gas chromatography with nitrogen-phosphorus detection. J Clin Pharmacol (1985) 1.08
Cosmic X-ray Sources. Science (1965) 1.08
Binding of Legionella pneumophila to macrophages increases cellular cytokine mRNA. Infect Immun (1994) 1.08
Serologic and parasitologic responses of domestic chickens after oral inoculation with Toxoplasma gondii oocysts. Am J Vet Res (1993) 1.08
Lymphoid cell blastogenesis as an in vitro indicator of cellular immunity to Legionella pneumophila antigens. J Clin Microbiol (1984) 1.08
A rapid [3H]glucose incorporation assay for determination of lymphoid cell-mediated inhibition of Candida albicans growth. J Immunol Methods (1986) 1.08
Antibody-mediated bacteriolysis: enhanced killing of cyclacillin-treated bacteria. Proc Soc Exp Biol Med (1976) 1.07
Transient lateral patellar dislocation: diagnosis with MR imaging. AJR Am J Roentgenol (1993) 1.07
Perinatal correlates of cerebral palsy and other neurologic impairment among very low birth weight children. Pediatrics (1998) 1.06
Migration of mouse lymphocytes in vitro from capillary tube cultures. Proc Soc Exp Biol Med (1969) 1.06
Immunosuppression and the role of suppressive factors in cancer. Adv Cancer Res (1977) 1.06
Stimulation of an enhanced in vitro immune response by a synthetic adjuvant, muramyl dipeptide. J Immunol (1978) 1.06
Development of antibody-forming cells in neonatal mice: stimulation and inhibition by calf thymus fractions. J Immunol (1970) 1.06
Human umbilical cord blood: a clinically useful source of transplantable hematopoietic stem/progenitor cells. Int J Cell Cloning (1990) 1.05
Volvulus of the sigmoid colon in Brazil: a report of 230 cases. Dis Colon Rectum (1976) 1.05
Human submandibular saliva aggregates HIV. AIDS Res Hum Retroviruses (1993) 1.05
Effects of RES "blockade" on antibody formation. II. Cytokinetics of the secondary haemolysin response and suppressed immunological "memory" in mice treated with carbon particles. Immunology (1969) 1.05